Drugs, Diseases, and the Managed Care Impact 

• NASH Emerging Market: Preparing Managed Care for Early Intervention, Equitable Access, and Integrating the Patient Voice
• Evaluating Biosimilar Real-World Evidence, Ongoing Trends, and Market Expansion in Rheumatology
• Future of Cell and Gene Therapy Management: There is More Than Value-Based Contracting!
• "Weighing In" on Glucagon-Like Peptide-1 Receptor Agonist Utilization Management Strategies and Real-World Clinical Outcomes

Keynote

• Innovative Contracting: Value-Based Strategies and Global Trends  
• 2023-2024 Health Care and Pharmaceutical Marketplace Trends
• Specialty Pharmaceutical Pipeline 2024

Legislative and Regulatory Trends

• Federal Legislative and Regulatory Update
• Health Care Reform and the Impact of PBM Legislation
• State Legislative and Regulatory Update
• Strategies to Navigate Medicare’s Health Equity-Related Changes: Leveraging SDOH Member Data and Optimizing Star Ratings
• An Update on IRA: What's Your Perspective?

Focus on Managed Care Pharmacy

• Navigating the Intersection of Managed Care Pharmacy and Patient Engagement

Managed Care Research in Action

• Best Practices in Peer-reviewed Publishing

Making the Way for Innovation 

• You Can Round That! Establishing and Managing Mandatory Drug Wastage Programs
• AMCP Talks: Innovative Approaches to Integrating the Patient Experience